Co-Authors
This is a "connection" page, showing publications co-authored by ANANTH ANNAPRAGADA and KETANKUMAR GHAGHADA.
Connection Strength
6.704
-
Nanoprobes for Computed Tomography and Magnetic Resonance Imaging in Atherosclerosis Research. Methods Mol Biol. 2022; 2419:809-823.
Score: 0.808
-
Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
Score: 0.590
-
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
Score: 0.567
-
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011 Jan; 18(1):20-30.
Score: 0.377
-
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
Score: 0.348
-
Folate targeting of drug carriers: a mathematical model. J Control Release. 2005 May 05; 104(1):113-28.
Score: 0.255
-
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Jan 02; 160:100-106.
Score: 0.249
-
Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
Score: 0.235
-
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS). medRxiv. 2023 Mar 24.
Score: 0.220
-
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
Score: 0.213
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.210
-
A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden. Contrast Media Mol Imaging. 2021; 2021:6641384.
Score: 0.194
-
Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1534-1548.
Score: 0.190
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.185
-
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
Score: 0.175
-
Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
Score: 0.165
-
A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
Score: 0.163
-
NIR-II fluorescence imaging using indocyanine green nanoparticles. Sci Rep. 2018 09 27; 8(1):14455.
Score: 0.161
-
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4?1. Sci Rep. 2018 02 27; 8(1):3733.
Score: 0.155
-
Indocyanine green fluorescence in second near-infrared (NIR-II) window. PLoS One. 2017; 12(11):e0187563.
Score: 0.152
-
A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis. 2016; 52(2):731-45.
Score: 0.133
-
Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent. Sci Rep. 2015 May 18; 5:10178.
Score: 0.128
-
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94.
Score: 0.109
-
Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc. 2012; 2012:27-35.
Score: 0.107
-
Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One. 2012; 7(4):e34496.
Score: 0.103
-
High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):18-22.
Score: 0.101
-
High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol. 2007 Jan; 28(1):48-53.
Score: 0.071
-
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol. 2006 Feb; 186(2):300-7.
Score: 0.067
-
Intratumoral nanofluidic system enhanced tumor biodistribution of PD-L1 antibody in triple-negative breast cancer. Bioeng Transl Med. 2023 Nov; 8(6):e10594.
Score: 0.057
-
Rational Design of a Self-Assembling High Performance Organic Nanofluorophore for Intraoperative NIR-II Image-Guided Tumor Resection of Oral Cancer. Adv Sci (Weinh). 2023 04; 10(10):e2206435.
Score: 0.054
-
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156.
Score: 0.046
-
A liposomal Gd contrast agent does not cross the mouse placental barrier. Sci Rep. 2016 06 14; 6:27863.
Score: 0.034
-
TmDOTA-tetraglycinate encapsulated liposomes as pH-sensitive LipoCEST agents. PLoS One. 2011; 6(11):e27370.
Score: 0.025
-
Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011 Apr; 2(4):298-304.
Score: 0.024
-
Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol. 2007 Mar; 14(3):355-62.
Score: 0.018
-
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med. 2006 May; 55(5):1023-9.
Score: 0.017